INSIGHT INTO NEW TECHNOLOGIES
Evonik also obtains access to innovative technologies and new business options through its corporate venture capital activities.
We invest specifically in specialized technology funds and promising start-ups of strategic relevance to Evonik. This gives us an insight into new technologies and business activities that fit our growth strategy at a very early stage of development. New products and technologies are developed in joint projects. In this way we speed up our innovative process. Evonik has been involved in the venture capital business since 2012 and has made more than 20 investments in this time.
Strategic focus on the following
NUMAFERM, a biotechnology company, is working on more efficient production of peptides..
Peptides and their applications are of enormous interest for our Specialty Additives and Health & Care growth engines.
Digital Growth Fund I.
This fund provides capital for fast-growing young IndustrialTech and FinTech companies with proven and successful B2B business models.
Our investment in Digital Growth Fund I is a strong partnership that strengthens Evonik in an important field of the future: digitalization.